Apple and Eli Lilly Stocks Soar on AI Update and Positive Trial Results

Apple's AI update drew investor interest as Apple stock reached an all-time high of $317.40, before reversing course and ending Monday's session over 1% lower.

The company unveiled 'Siri AI,' a revamped assistant powered in part by Google Gemini technology, at its Worldwide Developers Conference. The new assistant can search through messages, emails, photos, and other content to help users locate information more efficiently.

Oscar Health shares also drew interest after the company reaffirmed its 2026 revenue guidance of $18.7 billion to $19 billion. CFO R. Scott Blackley said the 2026 fiscal year has started on a strong footing, supported by stable membership trends, favorable healthcare utilization patterns, and better-than-expected industry data.

Eli Lilly stock hit a record high of $1,182.73 after the company reported positive late-stage trial results for Foundayo, its oral obesity treatment. The results showed that Foundayo delivered stronger blood sugar control and greater weight reduction than several competing treatments for adults with Type 2 diabetes.